Vascular Endothelial Growth Factor/Placental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia

被引:18
|
作者
Procianoy, Renato S. [1 ,2 ]
Hentges, Claudia R. [1 ,2 ]
Silveira, Rita C. [1 ,2 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Pediat, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Newborn Sect, Porto Alegre, RS, Brazil
关键词
preterm neonates; VEGF/PIGF heterodimer; angiogenesis; respiratory distress syndrome; bronchopulmonary dysplasia; CHRONIC LUNG-DISEASE; PREMATURE-INFANTS; ANGIOGENESIS; VEGF; ASTHMA; PREECLAMPSIA; RECEPTOR-1; EXPRESSION; DISCOVERY;
D O I
10.1055/s-0035-1566294
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Bronchopulmonary dysplasia (BPD) is associated with changes in pulmonary angiogenesis. However, the role of the vascular endothelial growth factor/placental growth factor (VEGF/PIGF) heterodimer, an antiangiogenic factor, remains unknown in this disease. Objective To compare VEGF/PIGF levels in preterm infants with and without BPD. Methods This study was approved by the Institutional Review Board. Preterm neonates with birth weight <2,000 g and gestational age <= 34 weeks were included. Exclusion criteria were: neonates transferred from other institutions after 72 hours of life; death before blood collection; presence of major congenital malformations, inborn errors of metabolism, and early sepsis; and mothers with multiple pregnancies, TORCH infections, HIV infection, or autoimmune diseases. BPD was defined as the need for oxygen therapy for a period equal to or greater than 28 days, accompanied by radiographic changes compatible with the disease. Blood was collected from neonates in the first 72 hours of life. VEGF/PIGF levels were measured using the enzyme-linked immunosorbent assay method. The chi-square test, t-test, Mann Whitney test, analysis of variance, and Kruskal Wallis test were used for statistical analysis. Variables found to be significant in the univariate analysis were included in the multivariate analysis. Results Seventy-three patients were included (19 with BPD, 43 without BPD, and 11 neonates who died in the first 28 days of life), with a mean (SD) gestational age of 30.32 (2.88) weeks and birth weight of 1,288 (462) g. Median VEGF/PIGF levels were higher in the groups with BPD and death in the first 28 days of life than in the group without BPD (16.46 [IQR, 12.19-44.57] and 20.64 [IQR, 13.39-50.22], respectively, vs. 9.14 [IQR, 0.02-20.64] pg/mL], p < 0.001). Higher VEGF/P1GF levels remained associated with BPD and death in the first 28 days of life in the multivariate analysis. Conclusion Higher plasma VEGF/PIGF levels were found in preterm neonates with BPD and in those who died in the first 28 days of life, suggesting an important role of this substance in pulmonary vascular development.
引用
收藏
页码:480 / 485
页数:6
相关论文
共 50 条
  • [21] Association of a vascular endothelial growth factor polymorphism with the development of bronchopulmonary dysplasia in Japanese premature newborns
    Fujioka, Kazumichi
    Shibata, Akio
    Yokota, Tomoyuki
    Koda, Tsubasa
    Nagasaka, Miwako
    Yagi, Mariko
    Takeshima, Yasuhiro
    Yamada, Hideto
    Iijima, Kazumoto
    Morioka, Ichiro
    SCIENTIFIC REPORTS, 2014, 4
  • [22] Preterm infants developing bronchopulmonary dysplasia have decreased growth factor concentrations in bronchoalveolar lavage fluid
    Zimmermann, L. J. I.
    Been, J. V.
    Debeer, A.
    Kloosterboer, N.
    Kramer, B. W.
    van Iwaarden, J. F.
    NEONATOLOGY, 2008, 93 (04) : 333 - 333
  • [23] Vascular endothelial growth factor in human preterm lung
    Lassus, P
    Ristimäki, A
    Ylikorkala, O
    Viinikka, L
    Andersson, S
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (05) : 1429 - 1433
  • [24] Vascular endothelial growth factor and receptors in preterm CLD
    Gottstein, R
    Peake, M
    Bates, M
    Vince, G
    Subhedar, NV
    PEDIATRIC RESEARCH, 2003, 54 (04) : 560 - 560
  • [25] Plasma apelin and vascular endothelial growth factor levels in preterm infants: relationship to neonatal respiratory distress syndrome
    Zhang, Yimin
    Shao, Shuming
    Mu, Qing
    Feng, Jing
    Liu, Jie
    Zeng, Chaomei
    Qin, Jiong
    Zhang, Xiaorui
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (25): : 10064 - 10071
  • [26] Placental growth factor (PlGF) and vascular endothelial growth factor (VEGF) in inflammatory skin disease
    Young, HS
    Janes, L
    Plant, D
    Worthington, J
    Griffiths, CEM
    Detmar, MJ
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01)
  • [27] Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells
    Mac Gabhann, F
    Popel, AS
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (01): : H153 - H164
  • [28] The levels of vascular endothelial growth factor-A and placental growth factor-2 in embryopathy associated with experimental diabetic gestation
    Salim, M. D.
    Al-Matubsi, Hisham Y.
    El-Sharaky, Ahmed S.
    Kamel, Maher A-N
    Oriquat, Ghaleb A.
    Helmy, Madiha H.
    El-Bassiouni, Emad A.
    GROWTH FACTORS, 2009, 27 (01) : 32 - 39
  • [29] Assessment of Maternal Serum Levels of Vascular Endothelial Growth Factor and Placental Growth Factor in Threatened Abortion: A Case Control Study
    Dev, Sugandha
    Singh, Alpana
    Banerjee, Bd
    Radhakrishnan, Gita
    Agarwal, Rachna
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (01) : QC16 - QC18
  • [30] Plasma levels of vascular endothelial growth factor and anti-vascular endothelial growth factor before and after intravitreal injection of anti-vascular endothelial growth factor
    Park, Sang Jun
    Yoon, Myung Hun
    Chung, Ah Reum
    Chin, Hee Seung
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)